An Exploratory Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-NK in the Treatment of Relapsed and Refractory IgG4-related Disease
Clinical trial NCT07298590 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07298590
- Sponsor
- Changhai Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-30
- Primary completion
- 2028-06-26
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.